GCA launches first breast implant for 10 years

Medical device company GC Aesthetics (GCA), has launched its next generation of GCA breast implants, PERLE.

PERLE is a round breast implant with BioQ – surface technology and cohesive emunomic breast tissue dynamic gel.  

Carlos Reis Pinto, CEO at GC Aesthetics said: “Nothing beats the excitement of having the chance to announce the launch of our new revolutionary smooth opaque breast implant: PERLE.

“With PERLE, we complete our range of breast implants to best suit each patient’s and plastic surgeon’s individual needs. We back our commitment of being a global medical device company focused on aesthetic surgery, women’s health and patient security through a broad portfolio of secure and innovative solutions.”

The scientific features at the heart of this implant’s development led GC Aesthetics to choose the product’s name and slogan.

Mr. Pinto explains: “A pearl is a unique, lustrous gem, that conveys safety, security, but also premium, luxury and art… and that is what our PERLE is, a response to the market’s, plastic surgeons’, and patients’ needs: it is, the Art of Science.”

PERLE’s BioQ – surface is developed with reverse surface technology. With this new surface, GC Aesthetics has taken advantage of the benefits associated with low surface roughness – such as reduced inflammation, easier placement and incision, as well as lower risk of capsular contracture. 

PERLE’s Emunomic breast tissue dynamic gel is a sixth-generation gel which is cohesive, virtually unbreakable and gives projection, fullness and firmness. 

Its softness and cohesivity gives surgeons the potential for smaller incisions, easier insertion that can contribute to minimised trauma and as PERLE is 100% gel-filled, associated with the reduced potential of wrinkling. 

PERLE is GC Aesthetics’ third launch of the year after HydroCone, its breast delivery system, and the addition of the Comfort Plus Warranty. 

Ron Cosmas, CCO at GC Aesthetics added: “GCA has no plans of slowing down. We will continue to expand upon the most diversified product on the market today to ensure that we can meet the needs of each surgeon and each individual unique patient. We will remain committed to leverage our technical expertise, forged by over 40 years of dedication to women around the world to offer the safest, most reliable products.”